Tufts to Remove Sackler Name from Medical Campus

The school will not return donations from the family that made its riches on opioids, but the university will start a $3 million endowment for addiction prevention and treatment.

Written byEmily Makowski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: ALEJANDRO RAMIREZ-CISNEROS, TUFTS UNIVERSITY

Tufts University is stripping the Sackler name from its school of graduate biomedical sciences, medical education building, and medical school programs “immediately,” according to an announcement on the university’s website last Thursday (December 5).

The removal of the name from Tufts programs and buildings in downtown Boston is the latest in a series of pushbacks from schools and museums against the family that owns OxyContin-maker Purdue Pharma. The Louvre recently dropped the name from one of its wings, according to STAT, and London’s Science Museum was criticized for complying with the family to repurpose a donation, reports The Guardian.

The Sacklers and Purdue Pharma have given about $15 million total to Tufts since 1980, and some of the research they funded was specifically related to pain management. The school will not return the donated money, but plans to start a $3 million endowment for addiction ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies